Telomir Pharmaceuticals logo

Telomir Pharmaceuticals

TELO | NASDAQ
Chart Builder DCF Calculator
$0.49
-$0.01 (-2.08%)
At close: Nov 13, 2026, 4:00 PM ET
$0.50
+$0.01 (+2.45%)
After-hours: Nov 13, 2026, 7:30 PM ET
-2.08%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 13, 2026
28.8
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #833/1022 (Top 82%)

Key Statistics

Market Data

Market Cap $36.15M
1D Range
0.49 0.57
52W Range
0.49 1.49

Valuation (TTM)

PE -0.33
PB 8.21
EV/EBITDA -6.63

Valuation (NTM)

Forward PE N/A
Forward PEG 0.01
Price Target $4.00
Loading financial charts...

Profile

Telomir Pharmaceuticals, Inc. operates as a preclinical-stage pharmaceutical firm, concentrating its efforts on creating and launching novel therapeutic interventions. Its primary focus involves the d...

Sector Healthcare
Industry Biotechnology
Employees 2
IPO Date Feb 9, 2024
Fiscal Year January - December

Latest News

No news articles available yet.

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.